Dana-Farber Research News 05.15.2026 - Takeaways - MDSpire
Advertisement
Dana-Farber Research News 05.15.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from April 16 - 30.
Dana-Farber's Research News highlights recent studies by faculty, focusing on advancements in cancer research published from April 16 to 30, 2026.
2
Chronic lymphocytic leukemia (CLL) research emphasizes the need for curative therapies, especially for high-risk patients with specific genetic disruptions.
3
A study identified cycling regulatory T cells as key players in immune escape during breast cancer progression, suggesting new immuno-oncology targets.
4
Transposable elements are proposed as a new hallmark of cancer, contributing to inflammation and anti-tumor immune responses during oncogenic transformation.
5
The LEAP-010 study evaluates the efficacy of pembrolizumab combined with lenvatinib as first-line therapy for recurrent or metastatic head and neck cancer.
